Life Science ETFs Performance 2018-2019: FBT is the Leader…Updates 2/7

cyklokapron cost ireland by | Feb 4, 2019 | 2009-2017 Life Science Portfolios, 2018 Rayno Biopharmaceuticals Portfolio, Clinical Diagnostics and Tools

careprost eye drops price in india Update 2/7/19 Mid-Day Trading : Risk Off Day The market is trending down with all major indices in the red and the XBI $81.96 down 2.75%. We sold our position in the XBI yesterday at $83+. Array (ARRY) continues to run up at $21.60. Hot stock MacroGenics (MGNX) cooled...

Biotechs Sell-Off Last Week: Growth Disappointing or Just Profit Taking? …Updates

aggrenox indirect purchaser settlement by | Jul 29, 2018 | 2018 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals

rhinocort cost Update 7/30 at close- -Large Caps Outperform-Very Weak Tape NASDAQ continues slide down 1.39% Large Cap Leaders ABBV up 0.89%, BMY up 3.53%, CELG up 2.87%,MRK up 2%,REGN up 1.06%, VRTX up 1.35%. BIIB down 2.63%. Mid-Cap Red Screen:  ACAD down 4.08%, ALNY down 7.37%,...

Biotech Bull Market: ETFs and Life Science Mutual Funds 2018 YTD

exelon historical stock prices by | Jun 30, 2018 | 2009-2017 Life Science Portfolios, 2018 Rayno Biopharmaceuticals Portfolio

tobradex eye ointment price philippines Biotech Bull Market: Up 25.39% Over 2 Years With High Volatility  XBI Outperforms Up 12% YTD; FBT is Comparable, IBB lags. Three Funds did well in H1 2018 (7-9%). Biotech stocks peaked in July 2015 and reached a bottom on 10/31/16 gradually clawing their way back to a...

Pin It on Pinterest